Literature DB >> 25745966

[Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis].

Mai Mishima1, Masanori Makita, Yasuhisa Sando, Yoshikazu Yamamoto, Yasuhiro Shiote, Yoshitaka Hara, Kazuhiko Yamamoto, Kenji Imajo.   

Abstract

Paraneoplastic inflammation of the large vessels is a rare complication of myelodysplastic syndrome (MDS), and patients with MDS and systemic vasculitis have a poor prognosis. We present a 66-year-old male with MDS and large vessel vasculitis treated with azacitidine. Azacitidine administration improved his clinical symptoms, high fever and thickening of the arterial wall, and he achieved a complete bone marrow remission. However, 1 year later he showed progression of MDS. For MDS with vasculitis, intensive therapy, the same as that given to the high-risk group, should be considered and azacitidine administration may represent an efficacious treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25745966     DOI: 10.11406/rinketsu.56.35

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  1 in total

1.  Paraneoplastic Large-vessel Vasculitis Associated with Myelodysplastic Syndrome.

Authors:  Hiroki Yabe
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.